Bone substitutes in orthopaedic surgery: from basic science to clinical practice

Bone substitutes are being increasingly used in surgery as over two millions bone grafting procedures are performed worldwide per year. Autografts still represent the gold standard for bone substitution, though the morbidity and the inherent limited availability are the main limitations. Allografts, i.e. banked bone, are osteoconductive and weakly osteoinductive, though there are still concerns about the residual infective risks, costs and donor availability issues. As an alternative, xenograft substitutes are cheap, but their use provided contrasting results, so far. Ceramic-based synthetic bone substitutes are alternatively based on hydroxyapatite (HA) and tricalcium phosphates, and are widely used in the clinical practice. Indeed, despite being completely resorbable and weaker than cortical bone, they have exhaustively proved to be effective. Biomimetic HAs are the evolution of traditional HA and contains ions (carbonates, Si, Sr, Fl, Mg) that mimic natural HA (biomimetic HA). Injectable cements represent another evolution, enabling mininvasive techniques. Bone morphogenetic proteins (namely BMP2 and 7) are the only bone inducing growth factors approved for human use in spine surgery and for the treatment of tibial nonunion. Demineralized bone matrix and platelet rich plasma did not prove to be effective and their use as bone substitutes remains controversial. Experimental cell-based approaches are considered the best suitable emerging strategies in several regenerative medicine application, including bone regeneration. In some cases, cells have been used as bioactive vehicles delivering osteoinductive genes locally to achieve bone regeneration. In particular, mesenchymal stem cells have been widely exploited for this purpose, being multipotent cells capable of efficient osteogenic potential. Here we intend to review and update the alternative available techniques used for bone fusion, along with some hints on the advancements achieved through the experimental research in this field.

[1]  M. Barba,et al.  Adipose-Derived Mesenchymal Cells for Bone Regereneration: State of the Art , 2013, BioMed research international.

[2]  N. Soni,et al.  Tissue engineering in periodontal regeneration: A brief review , 2012, Dental research journal.

[3]  D Basu,et al.  Orthopaedic applications of bone graft & graft substitutes: a review. , 2010, The Indian journal of medical research.

[4]  C. Bünger,et al.  [Stimulation of bone healing with growth factors in orthopedic surgery]. , 2000, Ugeskrift for laeger.

[5]  Joseph M. Lane,et al.  Bone Morphogenic Protein Science and Studies , 2005, Journal of orthopaedic trauma.

[6]  M. Swiontkowski,et al.  Bone-graft substitutes , 1999, The Lancet.

[7]  Lonnie D Shea,et al.  Inductive tissue engineering with protein and DNA-releasing scaffolds. , 2006, Molecular bioSystems.

[8]  P. Byers,et al.  Gene Targeting in Stem Cells from Individuals with Osteogenesis Imperfecta , 2004, Science.

[9]  N. Ishiguro,et al.  Differential Effects of Culture-expanded Bone Marrow Cells on the Regeneration of Bone Between the Femoral and the Tibial Lengthenings , 2009, Journal of pediatric orthopedics.

[10]  K. Miyazono,et al.  BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. , 2005, Cytokine & growth factor reviews.

[11]  D. R. Sumner,et al.  Biologic Factors Affecting Spinal Fusion and Bone Regeneration , 1995, Spine.

[12]  J T Czernuszka,et al.  Collagen-calcium phosphate composites , 1998, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[13]  C. Bernardini,et al.  Genes and Molecular Pathways of the Osteogenic Process , 2012 .

[14]  Solon T. Kao,et al.  A review of bone substitutes. , 2007, Oral and maxillofacial surgery clinics of North America.

[15]  H. Pape,et al.  Autologous Bone Graft: Properties and Techniques , 2010, Journal of orthopaedic trauma.

[16]  A. Boccaccini,et al.  Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. , 2006, Biomaterials.

[17]  Antonios G Mikos,et al.  Review: mineralization of synthetic polymer scaffolds for bone tissue engineering. , 2007, Tissue engineering.

[18]  C. Rey,et al.  A resolution-enhanced Fourier Transform Infrared spectroscopic study of the environment of the CO32− ion in the mineral phase of enamel during its formation and maturation , 1991, Calcified Tissue International.

[19]  L. Titus,et al.  Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2 , 1998 .

[20]  A. Goodship,et al.  The compatibility of ceramic bone graft substitutes as allograft extenders for use in impaction grafting of the femur. , 2005, The Journal of bone and joint surgery. British volume.

[21]  P. Giannoudis,et al.  Fracture healing: the diamond concept. , 2007, Injury.

[22]  C. Diaz-Ledezma,et al.  [Bone allografts and the functions of bone banks]. , 2011, Revista medica de Chile.

[23]  Z. Jing,et al.  Platelet-derived growth factor (PDGF)-AA: a self-imposed cytokine in the proliferation of human fetal osteoblasts. , 2000, Cytokine.

[24]  T. Bauer,et al.  Bone graft substitutes , 2007, Skeletal Radiology.

[25]  D H Kohn,et al.  Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. , 2000, Biomaterials.

[26]  F. Michetti,et al.  Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models , 2008, Gene Therapy.

[27]  S. Ludwig,et al.  Osteoinductive bone graft substitutes , 2000, European Spine Journal.

[28]  T. Troczynski,et al.  Novel biomimetic hydroxyapatite/alginate nanocomposite fibrous scaffolds for bone tissue regeneration , 2013, Journal of Materials Science: Materials in Medicine.

[29]  M. Barba,et al.  Spinal Fusion in the Next Generation: Gene and Cell Therapy Approaches , 2014, TheScientificWorldJournal.

[30]  Antonios G. Mikos,et al.  Growth Factor Delivery for Tissue Engineering , 2000, Pharmaceutical Research.

[31]  V. Goldberg,et al.  Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a polyanhydride delivery vehicle. , 1989, Journal of biomedical materials research.

[32]  G L Kimmel,et al.  Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo. , 1981, Biomaterials.

[33]  Henning Schliephake,et al.  Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid--an experimental study in rats. , 2008, Biomaterials.

[34]  V. Goldberg,et al.  The biology of bone grafts. , 1993, Seminars in arthroplasty.

[35]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[36]  L Ryd,et al.  Rigid Fusion After Cloward Operation for Cervical Disc Disease Using Autograft, Allograft, or Xenograft: A Randomized Study With Radiostereometric and Clinical Follow-Up Assessment , 2000, Spine.

[37]  P S Ramani,et al.  Cervical spinal interbody fusion with Kiel bone , 1975, The British journal of surgery.

[38]  S D Cook,et al.  The Effect of Osteogenic Protein-1 on the Healing of Segmental Bone Defects Treated with Autograft or Allograft Bone , 2001, The Journal of bone and joint surgery. American volume.

[39]  F. Wang,et al.  Microwave Plasma Sintering and In Vitro Study of Porous HA/β-TCP Biphasic Bioceramics , 2004 .

[40]  R. Miron,et al.  Osteoinduction: a review of old concepts with new standards. , 2012, Journal of dental research.

[41]  S. Santavirta,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.

[42]  J. Schierholz,et al.  Implant infections: a haven for opportunistic bacteria. , 2001, The Journal of hospital infection.

[43]  Jason A Burdick,et al.  Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. , 2002, Biomaterials.

[44]  F. Castro Role of Activated Growth Factors in Lumbar Spinal Fusions , 2004, Journal of spinal disorders & techniques.

[45]  T. Board,et al.  Bone Allograft in the UK: Perceptions and Realities , 2013, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[46]  Christoph H. Lohmann,et al.  Chapter 13—Bone Graft Substitutes: Basic Information for Successful Clinical Use with Special Focus on Synthetic Graft Substitutes , 2003 .

[47]  L. Trombelli,et al.  A comparative study on the use of a HA/collagen/chondroitin sulphate biomaterial (Biostite) and a bovine-derived HA xenograft (Bio-Oss) in the treatment of deep intra-osseous defects. , 2004, Journal of clinical periodontology.

[48]  Andrew J. Ruys,et al.  A Ceramic‐Polymer Functionally Graded Material: A Novel Disk Prosthesis , 2008 .

[49]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[50]  Anna Tampieri,et al.  From wood to bone: multi-step process to convert wood hierarchical structures into biomimetic hydroxyapatite scaffolds for bone tissue engineering , 2009 .

[51]  P. Chavassieux,et al.  In vitro induction of a calcifying matrix by biomaterials constituted of collagen and/or hydroxyapatite: an ultrastructural comparison of three types of biomaterials. , 1993, Biomaterials.

[52]  Duu-Jong Lee,et al.  In vitro and in vivo release of gentamicin from biodegradable discs. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[53]  Yashavantha Kumar C,et al.  Calcium sulfate as bone graft substitute in the treatment of osseous bone defects, a prospective study. , 2013, Journal of clinical and diagnostic research : JCDR.

[54]  H. Schliephake,et al.  In vitro characterization of a slow release system of polylactic acid and rhBMP2. , 2007, Journal of biomedical materials research. Part A.

[55]  Peltier Lf The use of plaster of Paris to fill defects in bone. , 1961 .

[56]  N. Roveri,et al.  The role of magnesium on the structure of biological apatites , 1992, Calcified Tissue International.

[57]  D. Mooney,et al.  Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. , 1999, Journal of periodontal research.

[58]  Elisabetta Foresti,et al.  Magnesium influence on hydroxyapatite crystallization , 1993 .

[59]  Jason A Burdick,et al.  Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[60]  A. Dumitrescu Bone Grafts and Bone Graft Substitutes in Periodontal Therapy , 2011 .

[61]  Anna Tampieri,et al.  Biomimetic Mg- and Mg,CO3-substituted hydroxyapatites: synthesis characterization and in vitro behaviour , 2006 .

[62]  Viola Bullmann,et al.  A level-1 pilot study to evaluate of ultraporous β-tricalcium phosphate as a graft extender in the posterior correction of adolescent idiopathic scoliosis , 2009, European Spine Journal.

[63]  M. Manyalich,et al.  European quality system for tissue banking. , 2009, Transplantation proceedings.

[64]  Cato T Laurencin,et al.  Xenotransplantation in orthopaedic surgery. , 2008, The Journal of the American Academy of Orthopaedic Surgeons.

[65]  A. Bernstein,et al.  Biology of Growth Factors , 1988, Advances in Experimental Medicine and Biology.

[66]  Ileana Baldi,et al.  Bone Morphogenetic Proteins and Bone Defects: A Systematic Review , 2007, Spine.

[67]  K S TenHuisen,et al.  Effects of magnesium on the formation of calcium-deficient hydroxyapatite from CaHPO4.2H2O and Ca4(PO4)2O. , 1997, Journal of biomedical materials research.

[68]  F. Marini,et al.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. , 2005, Cytotherapy.

[69]  Timothy Ganey,et al.  Demineralized Bone Matrix for Fracture Healing: Fact or Fiction? , 2010, Journal of orthopaedic trauma.

[70]  W. Lattanzi,et al.  Gene therapy for in vivo bone formation: recent advances. , 2005, European review for medical and pharmacological sciences.

[71]  Y. Kato,et al.  Application of chitin and chitosan derivatives in the pharmaceutical field. , 2003, Current pharmaceutical biotechnology.

[72]  J. Sandbank,et al.  Inflammatory reactions associated with a calcium sulfate bone substitute. , 1999, Annals of transplantation.

[73]  B. Weiner,et al.  Efficacy of Autologous Growth Factors in Lumbar Intertransverse Fusions , 2003, Spine.

[74]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[75]  C. Kelly,et al.  The Use of a Surgical Grade Calcium Sulfate as a Bone Graft Substitute: Results of a Multicenter Trial , 2001, Clinical orthopaedics and related research.

[76]  K. Ishihara,et al.  Restoration of segmental bone defects in rabbit radius by biodegradable capsules containing recombinant human bone morphogenetic protein-2. , 2000, Journal of biomedical materials research.

[77]  Véronique Maquet,et al.  Tissue engineering of biphasic cartilage constructs using various biodegradable scaffolds: an in vitro study. , 2004, Biomaterials.

[78]  Chun-Hao Tsai,et al.  Using the Growth Factors-enriched Platelet Glue in Spinal Fusion and its Efficiency , 2009, Journal of spinal disorders & techniques.

[79]  M. Urist,et al.  A chemosterilized antigen-extracted autodigested alloimplant for bone banks. , 1975, Archives of surgery.

[80]  C. Bünger,et al.  Osteogenic protein 1 device increases bone formation and bone graft resorption around cementless implants , 2002, Acta orthopaedica Scandinavica.

[81]  J T Czernuszka,et al.  Collagen-hydroxyapatite composites for hard tissue repair. , 2006, European cells & materials.

[82]  S A Goldstein,et al.  Skeletal repair by in situ formation of the mineral phase of bone. , 1995, Science.

[83]  T. Turner,et al.  Use of a calcium sulfate-based bone graft substitute for benign bone lesions. , 2001, Orthopedics.

[84]  S. Boden,et al.  Biologic Enhancement of Spinal Fusion , 1995, The Orthopedic clinics of North America.

[85]  K. Shakesheff,et al.  Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). , 2001, Biomaterials.

[86]  D. Mooney,et al.  Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. , 2001, Critical reviews in eukaryotic gene expression.

[87]  A. Mikos,et al.  Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. , 2006, Advances in biochemical engineering/biotechnology.

[88]  D. Cochran,et al.  Mitogenic effects of growth factors on human periodontal ligament cells in vitro. , 1993, Journal of periodontology.

[89]  David J. Mooney,et al.  Controlled growth factor release from synthetic extracellular matrices , 2000, Nature.

[90]  K. Shakesheff,et al.  Growth factor release from tissue engineering scaffolds , 2001, The Journal of pharmacy and pharmacology.

[91]  I. Lieberman,et al.  Musculoskeletal Allograft Risks and Recalls in the United States , 2008, The Journal of the American Academy of Orthopaedic Surgeons.

[92]  C. Rey,et al.  Fourier transform infrared spectroscopic study of the carbonate ions in bone mineral during aging , 1991, Calcified Tissue International.

[93]  Tabata,et al.  The importance of drug delivery systems in tissue engineering. , 2000, Pharmaceutical science & technology today.

[94]  K. Shakesheff,et al.  Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. , 2001, Bone.

[95]  Xu Cao,et al.  Multiplicity of BMP Signaling in Skeletal Development , 2007, Annals of the New York Academy of Sciences.

[96]  S. Boden,et al.  Clinical application of the BMPs. , 2001, The Journal of bone and joint surgery. American volume.

[97]  Jiang Chang,et al.  Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[98]  A. Tencer,et al.  Controlled release of antibiotics from coated orthopedic implants. , 1996, Journal of biomedical materials research.

[99]  W. Tomford,et al.  Transmission of disease through transplantation of musculoskeletal allografts. , 1995, The Journal of bone and joint surgery. American volume.

[100]  H. Weiss,et al.  Studies of the Release from Human Platelets of the Growth Factor for Cultured Human Arterial Smooth Muscle Cells , 1978, Circulation research.

[101]  S. Savolainen,et al.  Iliac crest versus artificial bone grafts in 250 cervical fusions , 2005, Acta Neurochirurgica.

[102]  C. Charalambides,et al.  Poor results after augmenting autograft with xenograft (Surgibone) in hip revision surgery , 2005, Acta orthopaedica.

[103]  Rozalia Dimitriou,et al.  The use of bone graft substitutes in large cancellous voids: any specific needs? , 2011, Injury.

[104]  C. Sfeir,et al.  Critical aspects of tissue-engineered therapy for bone regeneration. , 2001, Critical reviews in eukaryotic gene expression.

[105]  S. Ichinose,et al.  The biocompatibility and osteoconductive activity of a novel hydroxyapatite/collagen composite biomaterial, and its function as a carrier of rhBMP-2. , 2001, Journal of biomedical materials research.

[106]  S. Boden,et al.  Overview of the Biology of Lumbar Spine Fusion and Principles for Selecting a Bone Graft Substitute , 2002, Spine.

[107]  N. Forest,et al.  Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. , 1995, Biomaterials.

[108]  Adam J Starr,et al.  Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures. , 2003, The Journal of bone and joint surgery. American volume.

[109]  A. Hutchinson,et al.  Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. , 2008, The Journal of bone and joint surgery. British volume.

[110]  Xu Cao,et al.  The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine , 2013, Nature Medicine.

[111]  D. Puleo,et al.  In vitro effects of combined and sequential delivery of two bone growth factors. , 2004, Biomaterials.

[112]  Alyssa Panitch,et al.  Polymeric biomaterials for tissue and organ regeneration , 2001 .

[113]  S D Cook,et al.  The use of osteogenic protein-1 in reconstructive surgery of the hip. , 2001, The Journal of arthroplasty.

[114]  Lin Lu,et al.  Porogen-based solid freeform fabrication of polycaprolactone-calcium phosphate scaffolds for tissue engineering. , 2006, Biomaterials.

[115]  C. Bünger,et al.  Osteogenic protein-1 increases the fixation of implants grafted with morcellised bone allograft and ProOsteon bone substitute: an experimental study in dogs. , 2007, The Journal of bone and joint surgery. British volume.

[116]  R Cancedda,et al.  Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. , 2000, Journal of cell science.

[117]  A. Coetzee Regeneration of bone in the presence of calcium sulfate. , 1980, Archives of otolaryngology.

[118]  R. Roaf BONE GRAFTING , 1944, Nursing times.

[119]  K. Popat,et al.  Bone tissue engineering: A review in bone biomimetics and drug delivery strategies , 2009, Biotechnology progress.

[120]  T. Turner,et al.  Resorption evaluation of a large bolus of calcium sulfate in a canine medullary defect. , 2003, Orthopedics.

[121]  F. Luyten,et al.  Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology , 2011, Journal of cellular and molecular medicine.

[122]  I Harvey,et al.  Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. , 2007, Health technology assessment.

[123]  H. Kondo,et al.  Platelet-derived growth factor in combination with collagen promotes the migration of human skin fibroblasts into a denuded area of a cell monolayer. , 1992, Experimental cell research.

[124]  M. Ramchandani,et al.  In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[125]  David J. Mooney,et al.  Spatio–temporal VEGF and PDGF Delivery Patterns Blood Vessel Formation and Maturation , 2007, Pharmaceutical Research.

[126]  Horst A von Recum,et al.  Electrospinning: applications in drug delivery and tissue engineering. , 2008, Biomaterials.

[127]  L. Peltier,et al.  The Use of Plaster of Paris to Fill Defects in Bone , 1957, Annals of surgery.

[128]  A BAUERMEISTER,et al.  A method of bone maceration; results in animal experiments. , 1957, The Journal of bone and joint surgery. American volume.

[129]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[130]  E B Siqueira,et al.  Cervical Interbody fusion using calf bone. , 1982, Surgical neurology.

[131]  G. Zych,et al.  Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.

[132]  P. Ma,et al.  Polymeric Scaffolds for Bone Tissue Engineering , 2004, Annals of Biomedical Engineering.

[133]  C. Finkemeier,et al.  Bone-grafting and bone-graft substitutes. , 2002, The Journal of bone and joint surgery. American volume.

[134]  G. Logroscino,et al.  Bone Substitution in Spine Fusion: The Past, the Present, and the Future , 2014 .

[135]  Andrew I. Cooper,et al.  Polymer synthesis and processing using supercritical carbon dioxide , 2000 .

[136]  G. Grabowski,et al.  Bone Graft and Bone Graft Substitutes in Spine Surgery: Current Concepts and Controversies , 2013, The Journal of the American Academy of Orthopaedic Surgeons.

[137]  Justin W. Arner,et al.  A Historical Review of Common Bone Graft Materials in Foot and Ankle Surgery , 2014, Foot & ankle specialist.

[138]  Chi-Hwa Wang,et al.  Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[139]  R. Jones,et al.  Treatment of unicameral bone cysts by curettage and packing with plaster-of-Paris pellets. , 2004, The Journal of bone and joint surgery. American volume.

[140]  Peter Patka,et al.  Bone substitutes in the Netherlands - a systematic literature review. , 2011, Acta biomaterialia.

[141]  David J Mooney,et al.  Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. , 2006, Biomaterials.

[142]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[143]  Pierre-Yves Zambelli,et al.  Repair of critical size defects in the rat cranium using ceramic-reinforced PLA scaffolds obtained by supercritical gas foaming. , 2007, Journal of biomedical materials research. Part A.

[144]  J. Kohn,et al.  Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. , 1991, Biomaterials.

[145]  A. Hadjipavlou,et al.  Plaster of Paris as an Osteoconductive Material for Interbody Vertebral Fusion in Mature Sheep , 2000, Spine.

[146]  Jianwei Xie,et al.  Osteoblasts respond to hydroxyapatite surfaces with immediate changes in gene expression. , 2004, Journal of biomedical materials research. Part A.

[147]  G. Schmidmaier,et al.  Autograft versus BMPs for the treatment of non-unions: what is the evidence? , 2013, Injury.

[148]  Joseph A Buckwalter,et al.  Adverse reactions to OsteoSet bone graft substitute, the incidence in a consecutive series. , 2002, The Iowa orthopaedic journal.

[149]  E Rosset,et al.  Cervical Interbody Xenograft With Plate Fixation: Evaluation of Fusion After 7 Years of Use in Post‐Traumatic Discoligamentous Instability , 1996, Spine.

[150]  M. Drillings,et al.  Platelet alpha-granule proteins: studies on release and subcellular localization. , 1979, Blood.

[151]  C. Klein,et al.  Biodegradation behavior of various calcium phosphate materials in bone tissue. , 1983, Journal of biomedical materials research.

[152]  G. Logroscino,et al.  Sr-substituted hydroxyapatites for osteoporotic bone replacement. , 2007, Acta biomaterialia.

[153]  A. Gangi,et al.  Clinical results of an open prospective study of a bis-GMA composite in percutaneous vertebral augmentation , 2005, European Spine Journal.

[154]  A. Ladd,et al.  The role of bone graft and alternatives in unstable distal radius fracture treatment. , 2001, The Orthopedic clinics of North America.

[155]  H. Terheyden,et al.  Bone augmentation procedures in localized defects in the alveolar ridge: clinical results with different bone grafts and bone-substitute materials. , 2009, The International journal of oral & maxillofacial implants.

[156]  T. Tanabe,et al.  Preparation of collagen/calcium phosphate multilayer sheet using enzymatic mineralization. , 2004, Biomaterials.

[157]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[158]  S. Cartmell Controlled release scaffolds for bone tissue engineering. , 2009, Journal of pharmaceutical sciences.

[159]  S. Griffiths,et al.  In vivo performance of simvastatin-loaded electrospun spiral-wound polycaprolactone scaffolds in reconstruction of cranial bone defects in the rat model. , 2009, Journal of biomedical materials research. Part A.

[160]  G. Logroscino,et al.  Synthetic Biomimetic Nanostructured Hydroxyapatite , 2005 .

[161]  Anna Tampieri,et al.  Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour , 2008, Journal of materials science. Materials in medicine.

[162]  Joshua R Porter,et al.  Biodegradable poly(epsilon-caprolactone) nanowires for bone tissue engineering applications. , 2009, Biomaterials.

[163]  E. Pagano,et al.  Bioplasty for Vertebral Fractures: Preliminary Results of a Pre-Clinical Study on Goats Using Autologous Modified Skin Fibroblasts , 2011, International journal of immunopathology and pharmacology.

[164]  Ki Suk Park,et al.  Repair of diaphyseal bone defects with calcitriol-loaded PLGA scaffolds and marrow stromal cells. , 2007, Tissue engineering.

[165]  J Kent Leach,et al.  Multifunctional cell-instructive materials for tissue regeneration. , 2006, Regenerative medicine.

[166]  C. Friedman,et al.  BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. , 1998, Journal of biomedical materials research.

[167]  Søren Overgaard,et al.  No effect of Osteoset ® , a bone graft substitute, on bone healing in humans: A prospective randomized double-blind study , 2002, Acta orthopaedica Scandinavica.

[168]  Martyn C. Davies,et al.  Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials , 2001 .

[169]  W. Hutton,et al.  The Marshall R. Urist Young Investigator Award. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2. , 1998, Clinical orthopaedics and related research.

[170]  K. Anselme,et al.  Relationship between bioceramics sintering and micro-particles-induced cellular damages , 2004, Journal of materials science. Materials in medicine.

[171]  F. Cui,et al.  Synthesis of nanophase hydroxyapatite/collagen composite , 1995 .

[172]  A. Gasbarrini,et al.  Mesenchymal stromal cells multipotency and plasticity: induction toward the hepatic lineage. , 2009, European review for medical and pharmacological sciences.

[173]  K. Miyazono,et al.  Platelet-Derived Growth Factor , 2020, Definitions.

[174]  S. Glassman,et al.  Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.

[175]  M J Yaszemski,et al.  Polymer concepts in tissue engineering. , 1998, Journal of biomedical materials research.

[176]  M. Elorza,et al.  Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures. , 2007, Biomaterials.

[177]  Antonios G. Mikos,et al.  Review: Biodegradable Polymeric Scaffolds. Improvements in Bone Tissue Engineering through Controlled Drug Delivery , 2005 .

[178]  C. Bernardini,et al.  Undifferentiated human adipose tissue-derived stromal cells induce mandibular bone healing in rats. , 2011, Archives of otolaryngology--head & neck surgery.

[179]  W. Schlickewei,et al.  The Use of Bone Substitutes in the Treatment of Bone Defects – the Clinical View and History , 2007 .

[180]  G. Falini,et al.  Biologically inspired synthesis of bone-like composite: self-assembled collagen fibers/hydroxyapatite nanocrystals. , 2003, Journal of biomedical materials research. Part A.

[181]  R. Jinnah,et al.  The biology of bone grafting. , 1991, Orthopedics.

[182]  Seong-Hyeon Hong,et al.  Calcium Phosphate Bioceramics with Various Porosities and Dissolution Rates , 2004 .

[183]  D. Bueno,et al.  Is bone transplantation the gold standard for repair of alveolar bone defects? , 2014, Journal of tissue engineering.

[184]  Seong‐Hyeon Hong,et al.  Synthesis and dissolution behavior of β-TCP and HA/β-TCP composite powders , 2003 .

[185]  J. N. Rawlinson,et al.  Morbidity after anterior cervical decompression and fusion. The influence of the donor site on recovery, and the results of a trial of surgibone compared to autologous bone , 2005, Acta Neurochirurgica.

[186]  R. Ross,et al.  Platelet-derived growth factor--its role in health and disease. , 1988, Advances in experimental medicine and biology.

[187]  Cato T. Laurencin,et al.  Bone-Graft Substitutes: Facts, Fictions, and Applications , 2001, The Journal of bone and joint surgery. American volume.

[188]  G. Logroscino,et al.  Physico-chemical properties and solubility behaviour of multi-substituted hydroxyapatite powders containing silicon , 2008 .

[189]  D. Prockop,et al.  Medical therapies with adult stem/progenitor cells (MSCs): A backward journey from dramatic results in vivo to the cellular and molecular explanations , 2012, Journal of cellular biochemistry.

[190]  Shih-Jung Liu,et al.  Novel solvent-free fabrication of biodegradable poly-lactic-glycolic acid (PLGA) capsules for antibiotics and rhBMP-2 delivery. , 2007, International journal of pharmaceutics.

[191]  J. Baumhauer,et al.  Site Selection and Pain Outcome After Autologous Bone Graft Harvest , 2014, Foot & ankle international.